ArticleOpen forum infectious diseases2020

Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study.

Christoph D Spinner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.